Teladoc Health Logo
US87918A1051
A14VPK
TDOC

Teladoc Health

Loading quotes...

Forecast

The analysts' average price target is €7.90 (+41.83%). The median is €7.16 (+28.55%).

Buy
  15
Hold
  27
Sell
  0

  • BetterHelp and Sophia Bush launch The Permission Project to address women's mental health

    BetterHelp launched The Permission Project, a therapist-developed initiative partnered with Sophia Bush that provides a Rewrite Guide, 10,000 hours of free therapy and a $100,000 investment in therapists focused on women’s mental health. The program is based on research identifying social tensions—like being ambitious but likeable—that correlate with rising anxiety and depression among women and offers actionable steps to counter them. Bush, who contributed to the project, emphasizes systemic causes of women's unrecognized labor and the need for cultural change alongside individual support. » More on forbes.com


  • Teladoc Health appoints Michael Grasher as chief financial officer

    Teladoc Health has appointed Michael Grasher as CFO, effective immediately. Grasher has more than 30 years of experience in the insurance and financial services sector, including over 12 years in CFO roles at companies such as IFG Companies, Fortegra and AMERISAFE, and he also spent many years in equity research. » More on de.investing.com


  • Teladoc Health appoints Mark V. Anquillare to the board of directors

    Teladoc Health has appointed Mark V. Anquillare, former president and COO of Verisk Analytics, to its board of directors. He will serve on the audit and compensation committees and brings more than 30 years of experience in finance and leadership roles, including overseeing Verisk’s 2009 IPO. Anquillare also sits on several other boards; Teladoc Health provides virtual healthcare services through partnerships with insurers, employers and health systems. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2022, Teladoc Health has already paid €0.26 in dividends. The last payout was in March 2022.

Financials

In the last quarter, Teladoc Health had revenue of €531.8M and net profit of -€34.09M
(EUR) June 2026
YoY
Revenue 531.8M 0.81%
Gross profit 545.08M 45.56%
Net profit -34.09M 23.03%
EBITDA 54.38M 31.20%

Fundamentals

Metric Value
Market capitalization
€1.03B
Number of shares
181.68M
52-week high/low
€8.85 - €3.94
Dividends No
Beta
2.14
P/E ratio
-6.40
PEG ratio
-0.39
P/B ratio
0.87
P/S ratio
0.46

Company profile

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Name
Teladoc Health
CEO
Charles Divita
Headquarters New York, ny
USA
Website
Sector
Health Care
Industry
Health Care Providers & Services
IPO
06/30/2015
Employees 5,124

Ticker symbols

Exchange Symbol
NYSE
TDOC
London Stock Exchange
0LDR.L
XETRA
4LL.F
Frankfurt
4LL.F
DĂĽsseldorf
4LL.DU
London
0LDR.L
SIX
4LL.SW
MĂĽnchen
4LL.MU
🍪

Parqet  uses cookies. Learn more